New York, New York--(Newsfile Corp. - June 22, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Compass Diversified Holdings (NYSE: CODI) between May 1, 2024, and May 7, 2025, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Compass securities you may be entitled to compensation without payment of any out of pocket...
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med Promising tumor accumulation and attractive biodistribution shown in vivo, selective binding to membrane-bound MSLN with positive tumor to kidney ratio ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass. and PARIS, June 22, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX:...
New York, New York--(Newsfile Corp. - June 22, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 13, 2024 and February 10, 2025, both dates inclusive (the "Class Period"). The Class Period was expanded to include more investors. A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later...
New York, New York--(Newsfile Corp. - June 22, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ: IOVA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired...
New York, New York--(Newsfile Corp. - June 22, 2025) - WHY : Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Civitas Resources, Inc. (NYSE: CIVI) between February 27, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), of the important July 1, 2025 lead plaintiff deadline. SO WHAT : If you purchased Civitas Resources securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee...
New York, New York--(Newsfile Corp. - June 22, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Compass Diversified Holdings ("Compass" or "the Company") (NYSE: CODI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired...
KANEKA UBIQUINOL™ WINS COVETED MARKETING AWARD 2025 AT NATURAL HEALTH PRODUCTS NEW ZEALAND SUMMIT PR Newswire SYDNEY, June 23, 2025 SYDNEY , June 23, 2025 /PRNewswire/ -- Kaneka Corporation Supplement Division APAC, the world-renowned manufacturer and global supplier of Ubiquinol is thrilled to announce that Kaneka Ubiquinol™ has been awarded the prestigious Forbes Packaging Marketing Award 2025 at the Natural Health Products New Zealand (NHPNZ) Summit, further elevating the brand's position...
New York, New York--(Newsfile Corp. - June 22, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against NAPCO Security Technologies, Inc. ("NAPCO" or "the Company") (NASDAQ: NSSC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise...
New York, New York--(Newsfile Corp. - June 22, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Reddit, Inc. ("Reddit" or "the Company") (NYSE: RDDT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Reddit securities...
New York, New York--(Newsfile Corp. - June 22, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ: CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired...
New York, New York--(Newsfile Corp. - June 22, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 12, 2025. SO WHAT: If you purchased 3D Systems...
Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials PR Newswire INDIANAPOLIS, June 22, 2025 Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with weekly dosing Lilly plans to submit efsitora for the treatment of adults with type 2 diabetes to global regulatory agencies by the end of this year...
New York, New York--(Newsfile Corp. - June 22, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the "Class Period"), of the important July 22, 2025 lead plaintiff deadline. SO WHAT: If you purchased Organon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee...
New York, New York--(Newsfile Corp. - June 22, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. (NASDAQ: BITF) between March 21, 2023 and December 9, 2024, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff deadline . SO WHAT: If you purchased Bitfarms securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency...